The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,085,435 in first-year total cost, median $299,998.
Most frequent study sections
- Special Emphasis Panel[ZRG1 OTC-R (11)]7
- Special Emphasis Panel[ZRG1 MOSS-C (12)]3
- Special Emphasis Panel[ZRG1 VH-F (10)]1
Most frequent institutions
- FIBROPLATE, INC.2
- BCN BIOSCIENCES, LLC1
- BIOINCEPT, LLC1
- BOLDER BIOTECHNOLOGY, INC.1
- NELSON SCIENTIFIC LABS LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | A Novel Recombinant Protein for Mitigating Acute Radiation Injury2R44AI114218-03A1 | CHAUNG, WAYNE | THERASOURCE, LLC, NY | $974,383 | ZRG1 |
| 2020 | A multivalent, easy-to-use product to mitigate and treat radiation exposure2R44AI142964-02 | YEN, RICHARD | FIBROPLATE, INC., NV | $933,782 | ZRG1 |
| 2020 | Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury1R43AI155197-01 | JOHNSTONE, BRIAN H. | OSSIUM HEALTH, INC., CA | $299,998 | ZRG1 |
| 2020 | Metabolomics Based Prediction of Delayed Effects of Acute Radiation Exposure1R43AI155046-01 | CHEEMA, AMRITA KAURTYBURSKI, JOHN B. | NELSON SCIENTIFIC LABS LLC, MD | $292,628 | ZRG1 |
| 2019 | Senescence-Chips for Radiation Biodosimetry2R44AI106100-03A1 | WANG, DAOJING | NEWOMICS, INC, CA | $1,000,000 | ZRG1 |
| 2019 | Evaluation of a Novel Connexin-Based Peptide in the Treatment of Combined Ionizing Radiation and Thermal Burn Injury1R43AI142887-01A1 | GHATNEKAR, GAUTAM SUDHIR | XEQUEL BIO, INC., SC | $300,000 | ZRG1 |
| 2019 | Novel drugs combinations for improving survival from Acute Radiation Syndrome when administered 48h postirradiation1R43AI142909-01A1 | COX, GEORGE NORBERT | BOLDER BIOTECHNOLOGY, INC., CO | $300,000 | ZRG1 |
| 2019 | BCN057 as a mitigator of Radiation Induced Gastrointestinal Syndrome1R43AI145784-01A1 | NORRIS, ANDREW JOHNSAHA, SUBHRAJIT | BCN BIOSCIENCES, LLC, CA | $299,857 | ZRG1 |
| 2019 | Targeting Latexin for radiation mitigation.1R43AI145726-01 | GEIGER, HARTMUTLIANG, YING | P2D, INC., OH | $297,014 | ZRG1 |
| 2019 | Development of a novel therapy for mitigation of the irradiation-inducedgastrointestinal syndrome1R44AI138865-01A1 | BARNEA, EYTAN R | BIOINCEPT, LLC, OH | $207,237 | ZRG1 |
| 2019 | A multivalent, easy-to-use product to mitigate and treat radiation exposure1R43AI142964-01 | YEN, RICHARD | FIBROPLATE, INC., NV | $180,536 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.